Understanding ligand-based modulation of the Hsp90 molecular chaperone dynamics at atomic resolution
暂无分享,去创建一个
Giorgio Colombo | Giulia Morra | Massimiliano Meli | Gennady Verkhivker | G. Colombo | G. Morra | M. Meli | Gennady Verkhivker | Gennady M. Verkhivker
[1] J. Buchner,et al. Coordinated ATP Hydrolysis by the Hsp90 Dimer* , 2001, The Journal of Biological Chemistry.
[2] L. Neckers,et al. Heat shock protein 90 , 2003, Current opinion in oncology.
[3] Jason C. Young,et al. Hsp90: a specialized but essential protein-folding tool. , 2001, The Journal of cell biology.
[4] T. Straatsma,et al. THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .
[5] D. Picard,et al. Heat-shock protein 90, a chaperone for folding and regulation , 2002, Cellular and Molecular Life Sciences CMLS.
[6] J. Reinstein,et al. Intrinsic Inhibition of the Hsp90 ATPase Activity* , 2006, Journal of Biological Chemistry.
[7] Yves L Janin,et al. Heat shock protein 90 inhibitors. A text book example of medicinal chemistry? , 2005, Journal of medicinal chemistry.
[8] Peter G Wolynes,et al. Protein topology determines binding mechanism. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] Peter G Wolynes,et al. Localizing frustration in native proteins and protein assemblies , 2007, Proceedings of the National Academy of Sciences.
[10] Zhigang Xu,et al. Quantitative study of interactions between oxygen lone pair and aromatic rings: substituent effect and the importance of closeness of contact. , 2008, The Journal of organic chemistry.
[11] Peter G Wolynes,et al. A survey of flexible protein binding mechanisms and their transition states using native topology based energy landscapes. , 2005, Journal of molecular biology.
[12] L. Pearl,et al. Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex , 2006, Nature.
[13] G. Colombo,et al. Rational design of shepherdin, a novel anticancer agent. , 2005, Cancer cell.
[14] L. Neckers,et al. Heat shock protein 90: The cancer chaperone , 2007, Journal of Biosciences.
[15] N. Rosen,et al. Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90. , 2004, Chemistry & biology.
[16] C. Micheletti,et al. Structural and dynamical alignment of enzymes with partial structural similarity , 2007 .
[17] Paul Workman,et al. Inhibitors of the heat shock response: Biology and pharmacology , 2007, FEBS letters.
[18] L. Neckers,et al. Heat shock protein 90 as a molecular target for cancer therapeutics. , 2003, Cancer cell.
[19] Gennady M Verkhivker,et al. Energy landscape theory, funnels, specificity, and optimal criterion of biomolecular binding. , 2003, Physical review letters.
[20] K A Dill,et al. Ligand binding to proteins: The binding landscape model , 1997, Protein science : a publication of the Protein Society.
[21] G. Colombo,et al. Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead. , 2006, Journal of medicinal chemistry.
[22] David A. Agard,et al. Structural Analysis of E. coli hsp90 Reveals Dramatic Nucleotide-Dependent Conformational Rearrangements , 2006, Cell.
[23] L. Pearl,et al. Structure and mechanism of the Hsp90 molecular chaperone machinery. , 2006, Annual review of biochemistry.
[24] Giulio Superti-Furga,et al. Dynamic Coupling between the SH2 and SH3 Domains of c-Src and Hck Underlies Their Inactivation by C-Terminal Tyrosine Phosphorylation , 2001, Cell.
[25] Laurence H. Pearl,et al. A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone , 1997, Nature Structural Biology.
[26] C. Janiak,et al. Hydrogen-bonding, π-stacking and Cl−-anion–π interactions of linear bipyridinium cations with phosphate, chloride and [CoCl4]2− anions , 2005 .
[27] Paul Workman,et al. Overview: translating Hsp90 biology into Hsp90 drugs. , 2003, Current cancer drug targets.
[28] Neal Rosen,et al. Crystal Structure of an Hsp90–Geldanamycin Complex: Targeting of a Protein Chaperone by an Antitumor Agent , 1997, Cell.
[29] P. Wolynes,et al. The physics and bioinformatics of binding and folding—an energy landscape perspective , 2003, Biopolymers.
[30] M. Andreeff,et al. Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors. , 2006, Journal of the National Cancer Institute.
[31] W. Pratt,et al. Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery 1 , 2003, Experimental biology and medicine.
[32] S. Lindquist,et al. HSP90 and the chaperoning of cancer , 2005, Nature Reviews Cancer.
[33] J. Onuchic,et al. Multiple-basin energy landscapes for large-amplitude conformational motions of proteins: Structure-based molecular dynamics simulations , 2006, Proceedings of the National Academy of Sciences.
[34] R. Immormino,et al. Structure of Unliganded GRP94, the Endoplasmic Reticulum Hsp90 , 2005, Journal of Biological Chemistry.
[35] Wilfred F van Gunsteren,et al. Biomolecular modeling: Goals, problems, perspectives. , 2006, Angewandte Chemie.
[36] R. Immormino,et al. Ligand-induced Conformational Shift in the N-terminal Domain of GRP94, an Hsp90 Chaperone* , 2004, Journal of Biological Chemistry.
[37] F. Hartl,et al. In Vivo Function of Hsp90 Is Dependent on ATP Binding and ATP Hydrolysis , 1998, The Journal of cell biology.
[38] H. Berendsen,et al. Essential dynamics of proteins , 1993, Proteins.
[39] J. Schlitter. Estimation of absolute and relative entropies of macromolecules using the covariance matrix , 1993 .
[40] P. Wolynes. Recent successes of the energy landscape theory of protein folding and function , 2005, Quarterly Reviews of Biophysics.